These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 6486269

  • 1. Ratio of serum prolactin to haloperidol and early clinical outcome in acute psychosis.
    Swigar ME, Jatlow PI, Goicoechea N, Opsahl C, Bowers MB.
    Am J Psychiatry; 1984 Oct; 141(10):1281-3. PubMed ID: 6486269
    [Abstract] [Full Text] [Related]

  • 2. Correlates of early neuroleptic response using a uniform haloperidol dose.
    Bowers MB, Swigar ME, Jatlow PI, Hoffman FJ, Goicoechea N.
    Int Clin Psychopharmacol; 1987 Jul; 2(3):255-60. PubMed ID: 3693868
    [Abstract] [Full Text] [Related]

  • 3. Serum haloperidol concentrations and clinical response in acute psychosis.
    Miller DD, Hershey LA, Duffy JP, Abernethy DR, Greenblatt DJ.
    J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996
    [Abstract] [Full Text] [Related]

  • 4. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB, Swigar ME, Jatlow PI, Goicoechea N.
    J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
    [Abstract] [Full Text] [Related]

  • 5. Plasma concentrations of haloperidol and prolactin and clinical outcome in acutely psychotic patients.
    Aschauer HN, Schönbeck G, Langer G, Koinig G, Resch F, Hatzinger R, Chaudry HR, Sieghart W.
    Pharmacopsychiatry; 1988 Sep; 21(5):246-51. PubMed ID: 3227055
    [Abstract] [Full Text] [Related]

  • 6. Utility of neuroleptic blood levels in the treatment of acute psychosis.
    Zohar J, Shemesh Z, Belmaker RH.
    J Clin Psychiatry; 1986 Dec; 47(12):600-3. PubMed ID: 3782046
    [Abstract] [Full Text] [Related]

  • 7. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
    Neborsky RJ, Janowsky DS, Perel JM, Munson E, Depry D.
    J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration.
    Möller HJ, Kissling W, Lang C, Doerr P, Pirke KM, von Zerssen D.
    Am J Psychiatry; 1982 Dec; 139(12):1571-5. PubMed ID: 7149056
    [Abstract] [Full Text] [Related]

  • 9. Haloperidol blood levels in acute mania with psychosis.
    Chou JC, Czobor P, Dacpano G, Richardson N, Tuma I, Trujillo M, Cooper TB, Volavka J.
    J Clin Psychopharmacol; 2001 Aug; 21(4):445-7. PubMed ID: 11476130
    [Abstract] [Full Text] [Related]

  • 10. [Plasma monitoring of haloperidol. Correlation with clinical efficacy and plasma prolactin levels].
    Giraud-Serio J, Goyot C, Debray Q, Plaisant O, Grenier J, Pélicier Y.
    Ann Med Psychol (Paris); 1985 Nov; 143(9):900-11. PubMed ID: 3834819
    [No Abstract] [Full Text] [Related]

  • 11. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC, Vroulis G, Shvartsburd A, Allen R, Lewis N, Schoolar JC, Chojnacki M, Johnson R.
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [Abstract] [Full Text] [Related]

  • 12. Acutely psychotic patients receiving high-dose haloperidol therapy.
    Remington G, Pollock B, Voineskos G, Reed K, Coulter K.
    J Clin Psychopharmacol; 1993 Feb; 13(1):41-5. PubMed ID: 8486816
    [Abstract] [Full Text] [Related]

  • 13. Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?
    Arana GW, Goff DC, Friedman H, Ornsteen M, Greenblatt DJ, Black B, Shader RI.
    Am J Psychiatry; 1986 May; 143(5):650-1. PubMed ID: 3963258
    [Abstract] [Full Text] [Related]

  • 14. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
    Kulkarni J, Keks NA, Stuart G, Mackie B, Minas IH, Singh BS, Copolov DL.
    Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
    [Abstract] [Full Text] [Related]

  • 15. Relations between psychotic symptoms and serum prolactin levels.
    Roncoroni D.
    Pharmacopsychiatry; 1989 Mar; 22(2):71-5. PubMed ID: 2566181
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Haloperidol. Plasma monitoring and hormonal effects of treatment].
    Goyot C, Debray Q, Dugas M, Guay C, Giraud J, Grenier J.
    Pathol Biol (Paris); 1985 Dec; 33(10):999-1004. PubMed ID: 2937009
    [Abstract] [Full Text] [Related]

  • 18. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects].
    Schilkrut R, Haverbeck C, Duran E, Delgado S, Kohen P, Birkner R, Katz I.
    Acta Psiquiatr Psicol Am Lat; 1981 Dec; 27(4-5):315-24. PubMed ID: 7348089
    [Abstract] [Full Text] [Related]

  • 19. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC, Baumgartner R, Misra CH, Mauldin M, Shvartsburd A, Ho BT, DeJohn C.
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [Abstract] [Full Text] [Related]

  • 20. Serum prolactin as a correlate of clinical response to haloperidol.
    Van Putten T, Marder SR, Mintz J.
    J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.